Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway (Q28285114)

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Schizophrenia: an update and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Back signaling by the Nrg-1 intracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Localization of neuregulin-1alpha (heregulin-alpha) and one of its receptors, ErbB-4 tyrosine kinase, in developing and adult human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1 /- knock-outs compared with wild-type mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The EGF receptor family: spearheading a merger of signaling and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Regulation of NR1/NR2C N-methyl-D-aspartate (NMDA) receptors by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Cognition in female transmembrane domain neuregulin 1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

ErbB4 localization to interneurons: clearer insights into schizophrenia pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Delineation of additional PSD-95 binding domains within NMDA receptor NR2 subunits reveals differences between NR2A/PSD-95 and NR2B/PSD-95 association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Mutant models for genes associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Cognition in transmembrane domain neuregulin 1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulins: functions, forms, and signaling strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The neurodevelopmental hypothesis of schizophrenia, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

No NRG1 V266L in Chinese patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Association analysis of 94 candidate genes and schizophrenia-related endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

A Src link in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Postsynaptic density: a key convergent site for schizophrenia susceptibility factors and possible target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Bace1 modulates myelination in the central and peripheral nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

No significant association of the 5' end of neuregulin 1 and schizophrenia in a large Danish sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Parenteral administration of recombinant human neuregulin‐1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Schizophrenia is not associated with the functional candidate gene ERBB3: results from a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Signaling pathways in schizophrenia: emerging targets and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Phenotypic characterization of transgenic mice overexpressing neuregulin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

ErbB4 genotype predicts left frontotemporal structural connectivity in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Molecular mechanisms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Pathophysiologically based treatment interventions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Case-control study of association between the functional candidate gene ERBB3 and schizophrenia in Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Schizophrenia is not associated with the ERBB3 gene in a Han Chinese population sample: results from case-control and family-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Specific regulation of NRG1 isoform expression by neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Subchronic peripheral neuregulin-1 increases ventral hippocampal neurogenesis and induces antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The role of serotonin receptors in the action of atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Axonal neuregulin-1 regulates myelin sheath thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Bringing order to the glutamate chaos in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The extracellular linker of pro-neuregulin-alpha2c is required for efficient sorting and juxtacrine function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Association of the NRG1 gene and schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Axonal regulation of myelination by neuregulin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin signaling, cortical circuitry development and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

ErbB receptor signalling regulates dendrite formation in mouse cerebellar granule cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin and erbB Receptors Play a Critical Role in Neuronal Migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neurobiology: new order for thought disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Schizophrenia: A point of disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The involvement of ErbB4 with schizophrenia: association and expression studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Association of neuregulin 1 with schizophrenia confirmed in a Scottish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin 1 and susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin-1 type III determines the ensheathment fate of axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin beta/ADAM19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Structural and functional aspects of the multiplicity of Neu differentiation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Control of peripheral nerve myelination by the beta-secretase BACE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin-1 enhances depolarization-induced GABA release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Association study of neuregulin 1 gene with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

NMDA channel regulation by channel-associated protein tyrosine kinase Src.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Supranigral injection of neuregulin1-beta induces striatal dopamine overflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Support for involvement of neuregulin 1 in schizophrenia pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3003-2

Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke

21 January 2018

1 reference

12 December 2020

ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms

1 reference

12 December 2020

Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex

1 reference

12 December 2020

Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample

1 reference

12 December 2020

Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophrenia

1 reference

12 December 2020

Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample

1 reference

12 December 2020

Neuregulin genotype and medication response in Finnish patients with schizophrenia

1 reference

12 December 2020

Atypical antipsychotics: new drugs, new challenges.

1 reference

12 December 2020

Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.

1 reference

12 December 2020

A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure

1 reference

12 December 2020

Support for involvement of neuregulin 1 in schizophrenia pathophysiology

1 reference

12 December 2020

Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina

1 reference

12 December 2020

Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population

1 reference

12 December 2020

Differential localization of neuregulin-1 type III in the central and peripheral nervous system

1 reference

12 December 2020

Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation.

1 reference

12 December 2020

Association study of neuregulin 1 gene polymorphisms with auditory P300 in schizophrenia

1 reference

12 December 2020

Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus

1 reference

12 December 2020

Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport

1 reference

12 December 2020

Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells

1 reference

12 December 2020

Decreased peripheral expression of neuregulin 1 in high-risk individuals who later converted to psychosis

1 reference

12 December 2020

Binding specificities and affinities of egf domains for ErbB receptors

1 reference

12 December 2020

Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro

1 reference

12 December 2020

[Expressional changes of neuregulin-1 gene mRNA in peripheral blood from schizophrenia patients]

1 reference

12 December 2020

Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease

1 reference

12 December 2020

From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics

1 reference

12 December 2020

Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice

1 reference

12 December 2020

Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls

1 reference

12 December 2020

The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses

1 reference

12 December 2020

erbB3 is dispensable for oligodendrocyte development in vitro and in vivo

1 reference

12 December 2020